Trial intelligence / Profile preview

Efficacy of 3M CHG/IPA Prep (SoluPrep) on Skin Flora

NCT01968356Phase 3Terminated

Sponsor
Solventum
Start
Oct 2013
Primary completion
Jan 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of SoluPrep in surgical site infection (SSI), sponsored by Solventum. Started Oct 2013; status: terminated.

02

Drugs

SoluPrep
03

Conditions

surgical site infection (SSI)

Beyond the preview

Go deeper on NCT01968356.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01968356.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call